Evaluating the Role of Science Philanthropy in American Research Universities
Philanthropy plays a major role in university-based scientific, engineering, and medical research in the United States, contributing over $4 billion annually to operations, endowment, and buildings devoted to research. When combined with endowment income, university research funding from science phi...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
University of Chicago Press
2019
|
| Online Access: | http://hdl.handle.net/1721.1/120866 https://orcid.org/0000-0001-7570-8044 |
| Summary: | Philanthropy plays a major role in university-based scientific, engineering, and medical research in the United States, contributing over $4 billion annually to operations, endowment, and buildings devoted to research. When combined with endowment income, university research funding from science philanthropy is $7 billion a year. This major contribution to US scientific competitiveness comes from private foundations as well as gifts from individuals. From the researcher’s perspective, analysis in this paper demonstrates that science philanthropy provides almost 30% of the annual research funds of those in leading universities. And yet science philanthropy has been largely overshadowed by the massive rise of federal research funding and, to a lesser extent, industry funding. Government and industry funding have drawn intensive analysis, partly because their objectives are measurable: governments generally support broad national goals and basic research, while industry finances projects likely to contribute directly to useful products. In contrast, philanthropy’s contribution to overall levels of scientific funding and, more importantly, the distribution of philanthropy across different types of research are poorly understood. To fill this gap, I provide the first empirical evaluation of the role of science philanthropy in American research universities. The documented extent of science philanthropy and its strong emphasis on translational medical research raises important questions for federal policy makers. In determining their own funding strategies, they must no longer assume that their funding is the only source in shaping some fields of research while recognizing that philanthropy may ignore other important fields. |
|---|